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Abstract: Second-hand tobacco smoke (SHS) causes adverse health outcomes in adults. Further
studies are needed to evaluate psychosocial SHS exposure measures in comparison to SHS exposure biomarkers, particularly in pregnant women. This study aimed to compare self-reported SHS
exposure to urinary cotinine levels in pregnant women. A cross-sectional correlation design was
conducted using a convenience sample of 70 non-smoking pregnant women. Measures included
self-reported questionnaires and laboratory confirmation of cotinine levels in the urinary samples.
Multiple regression analysis was used to assess the correlation after controlling for potential confounding variables. The average level of urinary cotinine among non-smoking pregnant women was
6.77 ng/mL. Medium-strength correlations were found among psychosocial SHS exposure measures
and urine cotinine levels. Questions regarding ‘instances of smoking in front of the individual’ and
‘subjective perceived frequency of SHS exposure in past 7 days’ are feasible items for pregnant women
in clinics (particularly the first question). Hence, we suggest that these simple questions should be
used to assist pregnant women in reducing the harm associated with SHS exposure.

Received: 13 July 2021
Accepted: 28 August 2021
Published: 31 August 2021

Keywords: biomarkers; environmental tobacco smoke exposure; pregnant women; urine cotinine

Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affiliations.

Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).

1. Introduction
Despite global efforts to reduce active smoking, women and children are still exposed
to second-hand tobacco smoke (SHS) at home and the workplace. Studies from Spain,
Taiwan, and China revealed staggering rates of SHS exposure in non-smoking women.
The rate of SHS exposure has been reported to be 63.1% among non-smoking women
in Spain [1]. In Taiwan, SHS exposure among non-smoking pregnant women because
of their spouse’s smoking has been reported to be 46% [2]. In China, among 3165 nonsmoking households, 87% of the respondents reported that smokers would smoke in front
of them [3].
Studies have shown that SHS exposure causes premature death in children and
adults [4]. The harmful effects of SHS exposure may be increased in pregnant women
because of its effects on the developing organs in the foetus. In addition, prenatal SHS
exposure is associated with adverse effects on child health [5]. The adverse pregnancy and
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birth outcomes include small for gestational age [6], foetal growth restriction [7–10], poor
respiratory health during the first year of life [1], and stillbirth [11].
Reliable health information for SHS detection is a key component for the formulation of health policies and education programmes. Studies evaluating self-reported SHS
exposure to different biomarkers among public health and maternal populations have
reported mainly using self-reported methods [12–14]. Previous public health studies used
SHS exposure self-reported questionnaires to compare airborne nicotine levels [15] and
different cotinine biomarkers [16]. These two studies found a moderate association between
self-reported SHS questionnaire scores of an adult population and airborne nicotine and
cotinine biomarkers.
However, in non-smoking pregnant women, self-reported SHS exposure may be
underestimated. Xiao et al.’s study included 420 Chinese pregnant women residing in two
rural towns to compare self-reported SHS exposure to urinary cotinine levels [17]. Selfreported SHS exposure was obtained through face-to-face interviews and cotinine levels
were determined using urine samples. The self-reported rate of SHS was 76.9%, 83.3%, and
80.5% in the first, second, and third trimesters, respectively. The rate of urinary cotinineverified (UC-verified) SHS was determined using the limit of detection at 0.08 ng/mL by
high-performance liquid chromatography/tandem spectrometry. The self-reported rate of
SHS was 76.9%, 83.3%, and 80.5% in the first, second, and third trimesters, respectively,
whereas the rate of UC-verified SHS was 97.4%, 99.1%, and 98.6% in the first, second, and
third trimesters, respectively. The gradient differences between SHS exposure and urine
cotinine levels were 25.2%, 17.1%, and 20.5% in the first, second, and third trimesters,
respectively. It seems that self-reported SHS exposure is underestimated in rural Chinese
women partly due to methods used to determined urinary cotinine [17]. However, it is
unknown whether Chinese culture may influence pregnant women with self-reported
SHS exposure.
In the United States, Gavarkovs et al. [18] examined the consistency of SHS exposure
among two SHS self-reported measurements and salivary cotinine in 147 non-smoking
American women at 32 weeks’ gestation and 6 months postpartum. The first self-reported
measurement contained five different sites in the SHS exposure questionnaire. The second
self-reported SHS exposure used a validated scale of the ‘Environment Tobacco Smoke
Avoidance’ questionnaire. Higher values indicate greater avoidance of the SHS. Gavarkovs
et al. found that the SHS avoidance score was inversely associated with the number of SHS
exposure sites [18]. For example, the avoidance score (2.9) in two or more settings was
lower than one site (3.2 < 0.05). This finding suggests that proactive avoidance may be a
reliable method for detecting SHS exposure. Similarly, higher saliva cotinine with a higher
number of reported exposure locations suggested that the inclusion of more exposure
settings into questionnaire items may be favourable. Therefore, it is important to use
avoidance as an alternative to measuring SHS exposure.
Evaluating self-reported SHS exposure is less costly and non-invasive. However, the
quality of self-reported SHS exposure results may be influenced by recall errors, misclassification, the collection method, and social norms of smoking behaviour [5]. Chiang and
Chang [19] found that the rate of self-administered SHS exposure was 2–3% lower than
the rate of self-reported SHS exposure collected through face-to-face interviews. They
suggested that it is better to use interviews to increase the validity of self-reported SHS
exposure. Based on a literature review, we hypothesised that the household is an important factor influencing the accuracy of self-reported SHS exposure among non-smoking
pregnant women. This study aimed to compare self-reported SHS exposure to urinary
cotinine levels.
2. Materials and Methods
2.1. Study Design and Sampling
A cross-sectional, correlational design was used to examine the correlates of objective
exposure to SHS. This study involved data collection from October 2017 to February 2019.
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This study used structured questionnaires with a convenience sample of 70 participants at
a hospital in Midwest Taiwan. One hundred and six potential participants were invited to
participate in the study conducted in a waiting room of the maternal outpatient department (OPD) in a regional hospital. Seventy pregnant women met the inclusion criteria,
whereas 36 declined or did not meet the inclusion criteria. The response rate was 66%.
Potential participants were referred by a registered nurse in the maternal OPD. Thereafter, a
researcher was approached to determine whether the participants met the inclusion criteria.
Subsequently, one-on-one interviews were conducted to complete the self-reported SHS
questionnaire. Urine samples were collected on the same day of the prenatal care visit.
The inclusion criteria were as follows: (1) singleton pregnancy of 12–16 weeks, (2) age of
20–45 years, (3) ability to read Chinese and speak Mandarin or Taiwanese, and (4) residence in Chiayi for at least 6 months. We excluded women who smoked after pregnancy
confirmation or had pregnancy-related complications, such as placenta previa, gestational
diabetes mellitus, pregnancy-induced hypertension, cardiac disease, and premature rupture of membranes. A minimum of 68 participants were required to have 80% power
to yield significant results, with a medium effect size of f2 = 0.15 and an alpha level of
0.05 [20].
2.2. Ethical and Research Approvals
This study was approved by the institutional review board. Potential participants
were informed of its purposes, benefits, risks, and that their voluntary participation would
remain anonymous and confidential. They were also reassured that they could terminate
at any time. Those who agreed to participate provided written informed consent. The
anonymity of the study participants was warranted using a study identification number
without any personal identifiers.
2.3. Measurements
All instruments were obtained from self-reported questionnaires and laboratory confirmation of cotinine levels in urinary samples. Instruments and measures included the
following: (1) a structured demographic questionnaire, (2) subjective exposure to smoke, a
questionnaire regarding environmental tobacco smoke (SHS), and (3) objective exposure to
smoke (cotinine concentration level).
2.3.1. Demographic Characteristics
The demographic questionnaire included personal details, including age, weight,
height, education level, employment, and religion.
2.3.2. Subjective Exposure to Smoke
The self-reported SHS exposure questionnaire was used to determine the participants’
exposure at home, workplace, and public places; instances of smoking in front of participants (yes); the number of smokers at home; SHS exposure in the previous 7 days;
and their perceived frequency of SHS exposure in the previous 7 days, respectively. To
assess SHS exposure in the past 7 days, participants were selected from seven potential
exposure sources, including coffee shop or restaurants, car, their home and other houses,
malls or shopping centres, at or near schools, and work [21–23]. Response choices for each
source were never, once, a few times, more than a few times, and a lot. Responses for
this measure ranged from 0 to 28, with higher scores indicating greater exposure. The
perceived frequency of SHS exposure was based on a one-item scale that assessed the
degree of perceived frequency of exposure to SHS on a scale of 0 to 10 [23,24]. Higher
scores indicated greater perceived exposure.
2.3.3. Objective Exposure to Smoke
Nicotine is a common smoking biomarker. Cotinine is a nicotine metabolite, and
approximately 70–80% of absorbed nicotine is converted into cotinine [25]. In addition, it
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has a higher sensitivity and specificity than nicotine [25]. Urinary cotinine has a relatively
longer half-life (16–20 h) than nicotine [26]; however, the half-life of cotinine is much shorter
(16.6 h) for pregnancy [27]. Urinary cotinine is often used to assess SHS exposure because
it is non-invasive, and the average half-life of cotinine in the serum, urine, and saliva is
nearly similar [16,28,29]. A urine cotinine concentration of 100 ng/mL was used to identify
smokers in the general population [30,31]. Passive smokers and non-smokers showed
urinary cotinine levels of 40–100 ng/mL and <40 ng/mL, respectively [31]. However, the
clearance of nicotine and cotinine is significantly higher, and the half-life of cotinine is
much shorter during pregnancy [32]. Based on the study by Aurrekoetxea et al. [33], the
cut-off point for discriminating occasional smokers from non-smokers was 27 ng/mL (95%
confidence interval (CI), 11–43), and the cut-off point for differentiating non-SHS-exposed
from non-smokers was 19 ng/mL (95% CI, 11–33). In this study, the content of cotinine
in human urine was ascertained using ultra-performance liquid chromatography-tandem
mass spectrometry following the method described by Xu et al. [34].
2.3.4. Statistical Analysis
Data were analysed using frequency distributions and descriptive statistics. Before
performing regression analyses, t-tests, Pearson’s correlations, or Spearman rank correlation
were used to analyse the relationships among the variables. A two-step model-building
procedure was used to determine variables to assess the correlates of subjective to objective
SHS exposure (urinary cotinine levels) in a multivariate regression model. In the first step,
the variable selection was based on a causal path diagram created using R programs using
the directed acyclic graph (DAG) approach [35]. Covariates were selected based on the
recent literature [27,36–38], known correlates for SHS exposure in pregnant women, and
hypothesised relationships. The body mass index (BMI) was not included in the statistical
model for two reasons: (1) Baltar et al. found that the BMI was inversely associated
with cotinine concentration levels; however, this relationship was not observed in nonsmokers [36]; (2) There is no strong evidence that the BMI causally influences cotinine
levels [38]. Using the DAG approach, a priori model of the postulated relationships between
SHS exposure, urinary cotinine levels, and covariates was established. By adjusting for
these factors, the effect of all the described covariates in Figure 1 on the urinary cotinine
levels was investigated. Thereafter, univariate analyses were conducted to determine the
unadjusted associations between subjective and objective SHS exposure and potential
correlates. In the second step, as recommended by Hosmer et al. [39], only the variables
associated with urinary cotinine levels (p < 0.25) were included in the multivariate model.
Statistical significance was set at p < 0.05. Data analyses were conducted using SPSS 25
(IBM SPSS Inc., Chicago, IL, USA).

Figure 1. Directed acyclic graph representing the causal assumptions used for covariate selection.
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3. Results
3.1. Characteristics of the Participants
The descriptive characteristics of the participants are presented in Table 1. This study
included 70 women. The mean age was 32.0 years (standard deviation (SD) = 4.0 years)
with an average education level of 17.9 years (SD = 2.8 years). The mean body weight was
60.7 kg, and the BMI was 23.5 kg/m2 . Approximately half (n = 34, 48.6%) of the family
members of the study participants smoked before their pregnancy. In contrast, only a few
(n = 5, 7.5%) of the study participants’ partners and family members smoked in front of
the pregnant women. The average urinary cotinine level was 6.8± 6.3 ng/mL and ranged
from 1.0 to 41.1 ng/mL (Table 1).
Table 1. Characteristics of pregnant women in this study (N = 70).
Characteristics

Subjects N

N (%) or Mean ± Standard Deviation

Range

70
66
66
70
70

32.0 ± 4.0
60.7 ± 11.2
23.5 ± 3.9
17.9 ± 2.8
34 (48.6%)

24.0–44.0
40.2–95.0
17.6–35.9
12.0–21.0
–

67
70
64
69

5 (7.5%)
1.0 ± 1.2
3.2 ± 2.3
2.4 ± 2.2

–
0.0–5.0
0.0–28.0
0.0–10.0

70

6.0 (Median)

1.0–41.1

Demographic characteristics of participants
Age, year
Weight, kg
Body mass index, kg/m2
Education level, year
Family members smoke before pregnancy (yes)
Subjective exposure to smoke
Smoking in front of participants (yes)
Number of smokers at home
Perceived SHS exposure in past 7 days
Perceived frequency of SHS exposure in past 7 days
Objective exposure to smoke
Level of UC, ng/mL
UC Quartile, n (%)
0–25%
26–50%
51–75%
76–100%

21 (30.0%)
15 (21.4%)
17 (24.3%)
17 (24.3%)

SHS = second-hand smoke; UC = urinary cotinine.

Regarding the perceived frequency of SHS exposure in the past 7 days, the participants
reported that most of them did not perceive SHS exposure either at home, at work, or in
the car (n = 46, 67.6% vs. n = 41, 61.2% vs. n = 51, 77.3%). However, they were exposed
to SHS for 1 to 2 days in restaurant or coffee shop or shopping centre (n = 37, 55.2% vs.
n = 34, 50.0%). Additional information regarding the perceived frequency of SHS is shown
in Table 2.
Table 2. Perceived frequency of SHS in multiple sites among pregnant women.

In restaurant/Coffee
shop (n = 67)
Car (n = 66)
At home (n = 68)
In others house (n = 68)
In shopping
centre/Convenience
store (n = 68)
At/near school (n = 68)
At work (n = 67)

Never

1 to 2 Days/Week

3 to 4 Days/Week

5 to 6 Days/Week

7 Days/Week

N (%)

N (%)

N (%)

N (%)

N (%)

28 (41.8)

37 (55.2)

2 (3.0)

0 (0.0)

0 (0.0)

51 (77.3)
46 (67.6)
43 (63.2)

13 (19.7)
18 (26.5)
24 (35.3)

2 (3.0)
3 (4.4)
1 (1.5)

0 (0.0)
0 (0.0)
0 (0.0)

0 (0.0)
1 (1.5)
0 (0.0)

33 (48.5)

34 (50.0)

1 (1.5)

0 (0.0)

0 (0.0)

49 (72.1)
41 (61.2)

17 (25.0)
20 (29.8)

2 (2.9)
4 (6.0)

0 (0.0)
1 (1.5)

0 (0.0)
1 (1.5)
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3.2. Relationships between Exposure Variables of Interest and Urinary Cotinine Level
The results of multiple regression analyses are presented in Table 3. Based on the
several studies [36,38], the DAG approach and the correlation among the BMI, perceived
SHS exposure in the 7 past day, and the cotinine levels (r = −0.07 vs. r = 0.000, respectively),
it was excluded in the model. The correlation between urinary cotinine and correlates in
the univariate regression analyses were age, education (years), family members smoking
before pregnancy, the number of smokers at home, perceived SHS exposure in the past
7 days, perceived frequency of SHS exposure in the past 7 days, and smoking in front of the
participants. However, in the multivariate model, only smoking in front of the participants
and perceived frequency of SHS exposure in the past 7 days were significantly associated
with cotinine levels after controlling for potential confounders (F = 4.8, p = 0.002; Table 3).
Table 3. Univariate and multiple regression analysis of the factors associated with urinary cotinine levels of pregnant
women.
Urinary Cotinine Level

Univariate/Unadjusted

Multiple/Adjusted

ng/mL

B (95% CI)

p-Value

B (95% CI)

p-Value

Age/y
Education/y
Family members smoke before pregnancy
Smoking in front of participants
Number of smokers at home
Perceived SHS exposure in past 7 days
Perceived frequency of SHS exposure in past 7 days

−1.1 (−4.3 to 2.1)
−5.2 (−9.7 to 0.7) *
−12.8 (−37.9 to 12.2)
179.2 (39.5 to 118.9) **
8.7 (−1.8 to 19.2)
2.4 (−3.8 to 8.5)
6.1 (−2.1 to 14.3)

0.5
0.025 *
0.3
0.00 **
0.1
0. 5
0.1

−
−0.7 (−0.7 to 0.3)
−
0.6 (8.1 to 18.4) ***
−0.03 (−1.6 to 1.2)
−
0.3 (0.3 to 1.6) **

−
0.5
−
0.000 ***
0.8
−
0.004 **

Seven variables were analysed by univariate analysis and four variables that were associated with urinary cotinine levels (p < 0.25 were
included in the multivariate model, B = unstandardized regression coefficient; CI = confidence interval. * p < 0.05, ** p < 0.01, and
*** p < 0.001.

4. Discussion
The median of urinary cotinine level was 6.0 ng/mL and ranged from 1.0 to 41.1 ng/mL.
This result is consistent with the characteristics of participants who did not smoke and
were exposed to SHS. Studies have shown that, although nicotine can be absorbed by
SHS, the levels absorbed are insufficient to increase urine cotinine levels to greater than
500 ng/mL [40]. In addition, during pregnancy, blood and urinary cotinine levels are
often reduced due to increased renal clearance [32]. Our results regarding the range of
the urinary cotinine levels (1.0-41.1 ng/mL) are consistent with Aurrekoetxea et al. [33],
who reported the urine cotinine levels in the pregnant women exposed to SHS were above
19 ng/mL, depending on the duration and sources of SHS exposure.
This study is the first in Taiwan to validate measurements of psychosocial SHS exposure and urinary cotinine biomarkers. The results showed that two questions from
the questionnaire were significantly associated with cotinine biomarkers among pregnant
women (Table 3). This study adds to the body of knowledge of SHS exposure using a
self-reported method in a cohort of pregnant women [17,18,41–43]. Within the context
of this study, it is a Chinese social norm to avoid causing any harm during pregnancy,
including SHS exposure. Therefore, a strong awareness of avoiding harm may protect
Taiwanese pregnant women from SHS exposure. This may explain why a small portion of
participants reported SHS exposure in our study and demonstrated reliable evidence of
self-reported SHS exposure. Our results are similar to those of Govarkovs et al.’s study [18],
who reported that women’s avoidance of SHS exposure is consistent with cotinine levels.
In this study, the question item ’instances of smoking in front of the participant’ was
significantly associated with urinary biomarkers (β = 0.6, p < 0.001; Table 3). In addition,
the perceived frequency of SHS exposure in the past 7 days (β = 0.3, p = 0.004; Table 3)
was the most associated corelate, second only to ‘instances of smoking in front of the
participants’. Therefore, the proposed self-reported questions, ‘instances of smoking in
front of the participant’ and ‘subjective perceived frequency of SHS exposure in past 7 days’
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may be suitable, with relative confidence, to assess the SHS exposure in pregnant women
when objective measures are unavailable.
The results of this study are consistent with those of Okoli [16]. In the United States,
Okoli [16] surveyed 20 non-smoking adults to establish associations between various
biomarkers of SHS exposure and self-reported SHS survey questionnaires. Okoli [16] found
that hair nicotine yielded a moderate strength of association with the perceived frequency
of SHS exposure. Okoli’s study is further supported by Martinez-Sánchez et al.’s study [44],
who conducted a cross-sectional study involving 49 non-smoking volunteers to validate
airborne nicotine, urinary cotinine, and self-reported questionnaires of SHS exposure in
Spain. The survey questionnaire comprised two questions to gather information regarding
SHS exposure in the home setting: (1) the perception of the intensity of exposure to SHS in
the last 7 days based on a Likert scale based on high, medium, low, and very low response;
(2) to indicate a scale from zero to 10 about the perception of intensity of SHS exposure.
Martinez-Sánchez et al. found a positive relationship between the perception of SHS and
each direct SHS measure [44]. Moreover, a high correlation of scores with airborne nicotine
(r = 0.86, p < 0.05), salivary cotinine (r = 0.75, p < 0.05), and urinary cotinine (r = 0.62,
p < 0.05) was reported. This study supports that selected self-report questions may be
useful to assess SHS exposure at home.
Individuals’ homes may be a major place for SHS exposure for women and children
despite public education on reducing tobacco smoke exposure in homes [42,45,46]. Household members are still considered a strong predictor of SHS exposure among women and
children [2,45,47,48]. In a cohort of 18,845 Taiwanese children aged 18 months, it was
found that 62% of these children lived in a household with at least one smoker [48]. Cheng
et al. [48] further found that 84% of the smokers in the household were fathers of children.
Consistently, in Egypt, Abdelati et al. [45] also found that more than 50% of 118 pregnant
women were exposed to SHS by their spouses. In Japan, a study aimed at ascertaining the
validity of SHS exposure and plasma cotinine found that 63% of non-smoking pregnant
women were exposed to SHS [42]. According to the Health Promotion Administration,
Ministry of Health and Welfare (Taiwan) [46], campaigns to reduce smoking in the workplace and public led to a gradual decline in the prevalence of smoking Taiwan. However,
in this study, in contrast to individuals’ homes, restaurants/coffee shops or shopping
centres/convenience stores have the highest SHS (Table 2). Smoking in public and in the
workplace remains an issue [49]. Thus, those who stay for long durations at home and in
public places are at increased risk of SHS hazards. Therefore, reducing SHS exposure at
home and in public places remains an important challenge to be tackled. It is recommended
that the efforts of tobacco ban policy in public places should be maintained.
This study has some limitations that should be acknowledged. First, the small sample
size (n = 70) may increase the risk of type II errors, restricting the generalizability of the
findings. However, our sample size was sufficient for the study to have 80% power to
yield significant results (n = 68), with a medium effect size of f2 = 0.15 and an alpha level
of 0.05 [20]. Second, we only recruited and examined pregnant women in an outpatient
clinic or maternity care. Thus, the results might have potential selection bias and may
not generalise the national population of pregnant women in Taiwan. However, our
population characteristics are representative of the Taiwanese national profile specified
in the 2016 Family and Fertility Survey Report [50], which might have decreased the bias
of the single-centre study. In addition, sampling times could have impacted the urinary
cotinine level; therefore, the different urine sampling times may have been biased because
of the unknown time interval between reporting of SHS and urinary sampling. Finally,
our study did not collect hair to examine hair nicotine to detect the chronic influence of
SHS over a longer duration. The urinary cotinine level in pregnant women only represents
an acute-moderate impact of SHS within one day. Further studies may be needed using
hair samples to identify the association between long-term SHS exposure and self-report
questionnaires.
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5. Conclusions
This study provides additional data in the existing literature by investigating the
associations between metabolic components of SHS in urine and survey SHS exposure
measures to assess the representative items of SHS exposure among pregnant women.
Questions regarding ‘instances of smoking in front of the individual’ appears to be a feasible
question for use in pregnant women in clinics when assessing SHS exposure. Hence, we
suggest that this simple question should be included and monitored in clinical assessments
to support pregnant women in reducing the hazards associated with SHS exposure.
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